Companies » Company Overview » Ankur Drugs & Pharma Ltd.
 

Ankur Drugs & Pharma Ltd.

  • BSE: 531683
  • Sector: Health care
  • NSE: ANKURDRUGS
  • ISIN Code: INE238D01012
  • BSE

    LIVE

    05:30 | 01 Jan

  • Stock Is Not Traded.
  • NSE

    LIVE

    00:00 | 10 Sep

  • 3.65
  • 0
    (0.00%)
  • Open
    3.75
  • HIGH
    3.75
  • LOW
    3.65
 
 
This stock is not traded on BSE
NSE
00:00 AM,10th Sep 2013

3.65
0 (0.00%)
This stock is not traded on BSE
nse
00:00 AM,10th Sep 2013
3.65
0 (0.00%)
Previous Close 3.65
Volume 10260
52-Week high 3.75
52-Week low 0.00
P/E -
Mkt Cap.(Rs cr) 0
Bid Price 0.00
Bid Quantity 0.00
Offer Price 0.00
Offer Quantity 0.00

Ankur Drugs & Pharma Ltd. (ANKURDRUGS) - Company Information

Ankur Drugs and Pharma Ltd is engaged in contract manufacturing of pharmaceuticals formulations. The company has three manufacturing units: two in Himachal Pradesh and one in Daman. Its business segment includes pharmaceutical formulations in the form of tablets, capsules, liquid orals, oral powder, dry syrups, ointments, insta use suspension, form fill and seal (FFS), liquid injectables and dry powder injectables. Its clients include Ranbaxy Laboratories Limited, Cipla Limited, Sandoz Private L... [More]

STOCK STRENGTH
Today's Low/High
3.65
3.75
Week Low/High
0.00
3.75
Month Low/High
0.00
3.75
YEAR Low/High
0.00
3.75
All TIME Low/High
1.75
485.00
Peer Group
Company Last Change(%)
ABL Bio-Tech. 1.54 -0.65
Toheal Pharmach. 2.43 -1.62
Vardhaman Labs. 1.90 -4.52
Returns
Period Sensex NIFTY
1 Week NA -2.57% -2.26%
1 Month NA -1.27% -0.53%
3 Month NA 0.23% 0.62%
6 Month NA -7.10% -6.48%
1 Year NA 5.65% 7.59%
3 Year NA 63.07% 63.48%
Period Sensex NIFTY
1 Week NA -2.57% -2.26%
1 Month NA -1.27% -0.53%
3 Month NA 0.23% 0.62%
6 Month NA -7.10% -6.48%
1 Year NA 5.65% 7.59%
3 Year NA 63.07% 63.48%
Financial Results
Particulars (Rs cr) Dec 2012 Dec 2011 %Chg
Net Sales 36.12 38.5 -6.18
Other Income 0.01 0.01 0
Total Income 36.13 38.51 -6.18
Total Expenses 37.64 45.92 -18.03
Operating Profit -1.51 -7.41 79.62
Net Profit -40.84 -36.62 -11.52
Equity Capital 19.34 19.34 -
SHAREHOLDING PATTERN
As on Mar 2013
Company information
Chairman & Managing Director : Purnandu Jain
Whole Time Executive Director : Girraj Vijayvargiya
Director : Dileep Shinde
Director : Clifton Zimmermann
Company Secretary : S C Rane
Director : Ramesh Batham
AUDITOR: M G Vashi & Co
IND NAME: Pharmaceuticals - Indian - Formulations
HOUSE NAME: Indian Private
Registered office
C-306 Crystal Plaza, Andheri Link Road Andheri(W),
Mumbai,Maharashtra-400053
Ph: 91-22-40682300
E-mail: srane@ankurdrugs.com
URL: http://www.ankurdrugs.com

Quick Links

 
Quick Links for Ankur Drugs & Pharma

Back to Top